| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
76665957 |
| LAW OFFICE ASSIGNED |
LAW OFFICE 109 |
| MARK SECTION |
| STANDARD CHARACTERS |
YES |
| USPTO-GENERATED IMAGE |
YES |
| LITERAL ELEMENT |
XIAFLEX |
| OWNER SECTION (no change) |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| CURRENT IDENTIFICATION |
pharmaceutical preparations, namely collagenase enzyme used to treat fibroproliferative disease conditions such as Dupuytren's contracture,
Peyronie's disease and Frozen Shoulder Syndrome also known as Adhesive Capsulitis |
| GOODS OR SERVICES |
KEEP ALL LISTED |
| EXTENSION SECTION |
| EXTENSION NUMBER |
3 |
| ONGOING EFFORT |
product or service research development |
| ALLOWANCE MAIL DATE |
11/20/2007 |
| STATEMENT OF USE |
NO |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| SUBTOTAL AMOUNT |
150 |
| TOTAL AMOUNT |
150 |
| SIGNATURE SECTION |
| SIGNATURE |
/JAMES R. MEYER/ |
| SIGNATORY'S NAME |
JAMES R. MEYER |
| SIGNATORY'S POSITION |
ATTORNEY OF RECORD, PA BAR MEMBER |
| DATE SIGNED |
03/23/2009 |
| FILING INFORMATION |
| SUBMIT DATE |
Mon Mar 23 12:32:00 EDT 2009 |
| TEAS STAMP |
USPTO/ESU-XXX.XXX.XX.X-20
090323123200576259-766659
57-440f81cbd6135521ad9e3d
a0bf86ec52b9-DA-8196-2009
0323123015683053 |
| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: XIAFLEX
SERIAL NUMBER: 76665957
The applicant, AUXILIUM US HOLDINGS, LLC., having an address of
1105 N. MARKET STREET SUITE 1300
WILMINGTON, Delaware 19801
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 11/20/2007.
For International Class 005:
Current identification: pharmaceutical preparations, namely collagenase enzyme used to treat fibroproliferative disease conditions such as Dupuytren's contracture, Peyronie's disease and Frozen
Shoulder Syndrome also known as Adhesive Capsulitis
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /JAMES R. MEYER/ Date Signed: 03/23/2009
Signatory's Name: JAMES R. MEYER
Signatory's Position: ATTORNEY OF RECORD, PA BAR MEMBER
RAM Sale Number: 8196
RAM Accounting Date: 03/23/2009
Serial Number: 76665957
Internet Transmission Date: Mon Mar 23 12:32:00 EDT 2009
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.X-20090323123200576
259-76665957-440f81cbd6135521ad9e3da0bf8
6ec52b9-DA-8196-20090323123015683053